Distribution of glucocorticoid and mineralocorticoid receptors and 11β- hydroxysteroid dehydrogenases in human and rat ocular tissues

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 7, 2000, Pages 1629-1638

  Stokes, John ^a,b,d   Noble, June ^a   Brett, Lawrence ^a   Phillips, Calbert ^b   Seckl, Jonathan R ^a   O'Brien, Colm ^c   Andrew, Ruth ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

^c MATER PRIVATE HOSPITAL   (Ireland)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR;

ANIMAL TISSUE; ARTICLE; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; ENZYME ACTIVITY; EYE; HUMAN; HUMAN TISSUE; LENS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRABECULAR MESHWORK;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ANTERIOR EYE SEGMENT; ANTIBODIES, MONOCLONAL; CILIARY BODY; EPITHELIAL CELLS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; ISOENZYMES; MALE; RATS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RNA PROBES; RNA, MESSENGER;

EID: 0034116763     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. Invest Ophthalmol. 1963;70:482-491.
2. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500-507.
3. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992;33:2242-2250.
4. Yun AJ, Murphy CG, Polansky JR, Newsome DA, Alvarado JA. Proteins secreted by human trabecular cells: glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012-2022.
5. Hernandez MR, Weinstein BI, Dunn MW, Gordon GG, Southern AL. The effect of dexamethasone on the synthesis of collagen in normal human trabecular meshwork explants. Invest Ophthalmol Vis Sci. 1985;26:1784-1788.
6. Johnson DH, Bradley JM, Acott TS. The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest Ophthalmol Vis Sci. 1990;31:2568-2571.
7. Tripathi BJ, Tripathi RC, Swift HH. Hydrocortisone-induced DNA endoreplication in human trabecular cells in vitro. Exp Eye Res. 1989;49:259-270.
8. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trahecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
9. Wilson K, McCartney MD, Miggans ST, Clark AF. Dexamethasone-induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res. 1993;12:783-793.
10. Shirato S, Bloom E, Polansky J, Alvarado J, Stilwell L. Phagocytic properties of confluent cultured human trabecular meshwork cells [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1988;29(4):S125.
11. Snyder RW, Stamer WD, Kramer TR, Seftor RE. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res. 1993;57:461-468.
12. Putney LK, Brandt JD, O'Donnell ME. Effects of dexamethasone on sodium-potassium-chloride co-transport in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1997;38:1229-1238.
13. Becker B. Intraocular pressure responses to topical corticosteroids. Invest Ophthalmol. 1965;4:198-205.
14. Lewis JM, Priddy T, Judd J, et al. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open angle glaucoma Am J Ophthalmol. 1988;106:607-612.
15. Sayegh F, Weigelin E. Intraocular pressure in Cushing's syndrome. Ophthalmic Res. 1975;7:390-394.
16. Johnson DH, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997; 115:375-383.
17. Rohen JW, Lutjen-Drecoll E, Flugel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open angle glaucoma (POAG). Exp Eye Res. 1993;56:683-692.
18. Pallardy M. Glucocorticoid-induced apoptosis: transcriptional mechanisms (Abstract). Br J Pharmacol. 1997;122:448.
19. Weinreb R, Bloom E, Baxter JD, et al. Detection of glucocorticoid receptors in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1981;21:403-407.
20. Schwartz B, Wysocki A. Mineralocorticoid receptors in the rabbit iris-ciliary body. Ophthalmic Res. 1997;29:42-47.
21. Starka L, Hampl R, Obenberger J. Aldosterone binding in the bovine ciliary body. Endocrinol Exp. 1977;11:203-208.
22. Mirshahi M, Mirshahi A, Sedighian R, Hecquet C, Faure JP, Agarwal MK. Immunochemical demonstration of the mineralocorticoid receptor in ocular tissues. Neuroendocrinology. 1997;65:70-78.
23. Mirshahi M, Nicolas C, Mirshahi A, et al. The mineralocorticoid receptor and actions in the eye. Biochem Biophys Res Commun. 1996;219:150-156.
24. Starka L, Hampl R, Obenberger J, Doskocil M. The role of corticosteroids in the homeostasis of the eye. J Steroid Biochem. 1986; 24:199-205.
25. Lakshmi V, Monder C Purification and characterisation of corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology. 1988;123: 2390-2398.
26. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Human placental 11β-hydroxysteroid dehydrogenase: partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinology. 1993;132:2614-2621.
27. Rusvai E, Naray-Fejes-Toth A. A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem. 1993;268:10717-10720.
28. White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK. Molecular analysis of 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Steroids. 1997;62:83-88.
29. Mune T, White PC. Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype. Hypertension. 1996; 27:1193-1199.
30. Miesfeld R, Okret S, Wilkstrom AC, Wrange O, Gustafsson JA, Yamamoto KR. Characterisation of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature. 1984;312: 779-781.
31. Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1988;1:887-900.
32. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11-dehydrogenase. J Biol Chem. 1989;264:18939-18943.
33. Leckie C, Chapman KE, Edwards CRW, Seckl JR. LLC-PK1 cells model 11β-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology. 1995;136:5561-5569.
34. Seckl JR, Dickson KL, Yates C, Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human post-mortem hippocampus. Brain Res. 1991;561:332-337.
35. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11-beta-hydroxysteroid dehydrogenase: Structure, tissue distribution and chromosomal localisation. J Biol Chem. 1991;266:16653-16658.
36. Brown RW, Chapman KE, Kotelevtsev Y, et al. Cloning and production of antisera to human placental 11β-hydroxysteroid dehydrogenase type 2. Biochem. J. 1996;313:1007-1017.
37. Fuxe K, Wikstrom A-C, Okret S, et al. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 1985;117:1803-1812.
38. Ahima R, Krozowski Z, Harlan R. Type 1 corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol. 1991;313:522-538.
39. Lowry OH, Rosebrough NJ, Four AL, Randall RJ. Protein measurement with the Folen phenol reagent. J Biol Chem. 1951;193:265-275.
40. Walker BR, Yau JL, Brett LP, et al. 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129: 3305-3312.
41. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 1995;136:4754-4761.
42. Roland BL, Krozowski ZS, Funder JW. Glucocorticoid receptor, mineralocorticoid receptor, 11β-hydroxysteroid dehydrogenase-1 and dehydrogenase-2 expression in rat brain and kidney: in-situ studies. Mol Cell Endocrinol. 1995;111:R1-R7.
43. Agarwal MK. Perspectives in receptor-mediated mineralocorticoid hormone action. Pharmacol Rev. 1994;46:67-87.
44. +-ATPase in the epithelium of the rabbit ciliary body pars plicata. Invest Ophthalmol Vis Sci. 1988;29:606-614.
45. Brown S, Hedbys B. The effect of ouabain on the hydration of the cornea. Invest Ophthalmol. 1965;4:216-221.
46. Rozsival P, Hampl R, Obenberger J, Starka L, Rehak S Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Curr Eye Res. 1981;1:391-396.
47. Green K, Phillips CI, Gore SM, Elijah RD, Bowman KA, Cullen P. Ocular fluid dynamic response to topical RU486, a peripheral steroid blocker. Curr Eye Res. 1985;4:605-612.
48. Barnes PJ, Adcock IM. Steroid resistant asthma. Quart J Med. 1995;88:455-468.
49. Walker BR, Phillips DIW, Noone JP, Paranelli M, Andrew R, Edwards H. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension. 1998;31:891-895.
50. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endo Metab. 1998;83:1806-1809.